Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jake R Morgan

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Annals of Internal Medicine|March 31, 2015
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infectionBenjamin P Linas, Devra M Barter, Jake R Morgan, et al.
JAMA Network Open|September 13, 2023
Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use DisorderJuliet M Flam-Ross, Elizabeth Marsh, Michelle Weitz, et al.
JAMA Network Open|February 15, 2021
Projected Estimates of Opioid Mortality After Community-Level InterventionsBenjamin P Linas, Alexandra Savinkina, R W M A Madushani, et al.
JAMA Network Open|June 27, 2025
Health and Economic Outcomes of Addressing Encampments of Individuals Using OpioidsHana Zwick, Ryan O'Dea, Joshua A Barocas, et al.
Drug and Alcohol Dependence|November 5, 2020
Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities StudyArnie P Aldridge, Carolina Barbosa, Joshua A Barocas, et al.
Trials|January 28, 2023
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Linkage-to-Care Trial: rationale and design of an emergency department-based randomized clinical trial of linkage-to-care strategies for hepatitis CSarah E Rowan, Jason Haukoos, Kevin F Kamis, et al.
JAMA|July 9, 2025
Hepatitis C Screening in Emergency Departments: The DETECT Hep C Randomized Clinical TrialJason Haukoos, Richard E Rothman, James W Galbraith, et al.
Trials|April 26, 2022
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: rationale and design of a multi-center pragmatic randomized clinical trial of hepatitis C screening in emergency departmentsJason S Haukoos, Sarah E Rowan, James W Galbraith, et al.
Journal of Viral Hepatitis|March 12, 2022
Determining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral-based treatment regimens: Evidence from a global data setJake R Morgan, Elizabeth Marsh, Alexandra Savinkina, et al.
Drug and Alcohol Dependence|July 20, 2025
Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trialJennifer L Brown, Marc R Larochelle, Laura C Fanucchi, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Annals of Internal Medicine|March 31, 2015
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infectionBenjamin P Linas, Devra M Barter, Jake R Morgan, et al.
JAMA Network Open|September 13, 2023
Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use DisorderJuliet M Flam-Ross, Elizabeth Marsh, Michelle Weitz, et al.
JAMA Network Open|February 15, 2021
Projected Estimates of Opioid Mortality After Community-Level InterventionsBenjamin P Linas, Alexandra Savinkina, R W M A Madushani, et al.
JAMA Network Open|June 27, 2025
Health and Economic Outcomes of Addressing Encampments of Individuals Using OpioidsHana Zwick, Ryan O'Dea, Joshua A Barocas, et al.
Drug and Alcohol Dependence|November 5, 2020
Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities StudyArnie P Aldridge, Carolina Barbosa, Joshua A Barocas, et al.
Trials|January 28, 2023
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Linkage-to-Care Trial: rationale and design of an emergency department-based randomized clinical trial of linkage-to-care strategies for hepatitis CSarah E Rowan, Jason Haukoos, Kevin F Kamis, et al.
JAMA|July 9, 2025
Hepatitis C Screening in Emergency Departments: The DETECT Hep C Randomized Clinical TrialJason Haukoos, Richard E Rothman, James W Galbraith, et al.
Trials|April 26, 2022
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: rationale and design of a multi-center pragmatic randomized clinical trial of hepatitis C screening in emergency departmentsJason S Haukoos, Sarah E Rowan, James W Galbraith, et al.
Journal of Viral Hepatitis|March 12, 2022
Determining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral-based treatment regimens: Evidence from a global data setJake R Morgan, Elizabeth Marsh, Alexandra Savinkina, et al.
Drug and Alcohol Dependence|July 20, 2025
Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trialJennifer L Brown, Marc R Larochelle, Laura C Fanucchi, et al.
Pageof 8